Category Archives: Cardiovascular

Inhaler combination outperforms others in reducing COPD exacerbation, cardiovascular risks

August 23, 2023 3 min read Source/Disclosures Disclosures: The study authors report no relevant financial disclosures. Blagev reports no relevant financial disclosures. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . <button type="button" class="btn […]

Texas Heart Institute receives $1.14 million grant to develop first-in-class drug to treat cardiovascular disease

The National Heart, Lung, and Blood Institute (NHLBI) recently awarded The Texas Heart Institute® (THI) a two-year, $1.14 million grant to develop a novel, first-in-class drug to treat cardiovascular disease (CVD) as a significant improvement to current treatment regimens -; specifically for adverse events arising from atherosclerosis. Cardiovascular disease is the leading cause of death […]

Circulating microvesicles across a population with various degree of cardiovascular burden are associated with systolic blood pressure

Abstract Circulating microvesicles (MVs) have been studied in heterogeneous, divergent, and rather small patient populations with cardiovascular risk . Therefore, we measured endothelial (EMVs), platelet (PMVs) and erythrocyte (RMVs) MVs in patients with divergent cardiovascular risk. We then compared them to coronary artery disease (CAD) and healthy subjects and identified independent MVs’ predictors. We enrolled […]

Aspirin can help reduce risk of second heart attack, but study finds less than half of eligible adults take it

(CNN) — For adults who have survived a heart attack or stroke, taking aspirin regularly may reduce the risk of another cardiovascular event. But a new study suggests that less than half of these cardiovascular disease patients around the world are using aspirin to prevent a new event. Among people with a history of cardiovascular disease who were surveyed […]

AI-powered protein score predicts major atherosclerotic cardiovascular disease events

In a large retrospective analysis using measurements of thousands of plasma proteins in primary and secondary event populations, scientists from deCODE genetics a subsidiary of Amgen and collaborators from USA, Denmark and Iceland, reported today in The Journal of the American Medical Association (JAMA) how they employed AI to develop a protein score to predict […]

Protein Risk Score Alongside Genetic, Clinical Factors Modestly Improves Cardiovascular Disease Prediction

NEW YORK – Using data from an Icelandic population, researchers have developed a protein risk score to predict atherosclerotic cardiovascular disease (ASCVD). While the score by itself was significantly associated with ASCVD events, when it was added to a model that included clinical risk factors and polygenic risk scores for common heart conditions, it only […]

Why Is the Right So Obsessed with Seed Oils?

“Before seed oils were invented, everybody was hot and healthy,” reads the first sentence of an Aug. 21 tweet by Carnivore Aurelius, a Twitter account with more than 300,000 followers. The tweet cites statistics claiming to link consumption of seed oils to an increase in obesity and cardiovascular disease rates, embedding a photo of a […]

TAVR safe and effective for severe AS patients with a very low gradient

Patients were placed into three groups based on their resting aortic mean transvalvular gradient, as determined by transthoracic echocardiography. A high gradient was defined as ≥40 mmHg, a low gradient was defined as 26-39 mmHg and a very low gradient was defined as ≤25 mmHg. Overall, 57% of patients presented with a high gradient, 35% presented with […]

Protein score, from a single plasma sample, predicts atherosclerotic cardiovascular disease

Credit: Unsplash/CC0 Public Domain In a large retrospective analysis using measurements of thousands of plasma proteins in primary and secondary event populations, scientists from deCODE genetics and collaborators from U.S., Denmark and Iceland, reported today in JAMA how they employed AI to develop a protein score to predict major atherosclerotic cardiovascular disease events (ASCVD). The […]